Bisphosphonates Market Value Share, Supply Demand 2016-2026

Bone
resorption and bone formation takes place continuously in the body and is a
balanced process, but when there is imbalance in this process the bones get
dissolved by the osteoclasts and start losing calcium. This eventually leads to
osteoporosis and other conditions like hypercalcemia as the calcium mixed in
the blood. Bisphosphonates prevent bone damage and are used for bone
strengthening and hardening. Bisphosphonates are group of drugs having high
affinity for the bone tissue and are widely used for treatment of bone related
diseases like osteoporosis, myeloma and bone metastasis. With the rising
incidence rate of myeloma and geriatric population the Bisphosphonates market
is expected to show healthy growth during the forecast period.

The
Bisphosphonates market is mainly driven by the incidence and prevalence rate of
bone diseases. The expansion in geriatric population is the major driver for
the bisphosphonates market. Ageing people start losing bone density and may
suffer from fractures therefore bisphosphonate treatment becomes necessary for
such patients. According to the U.S. Department of Health and Human Services,
2013 survey, nearly 14.1% of the U.S. population was aged above 65 years and is
increasing rapidly. Another significant factor favorable for the growth of
bisphosphonates market is the escalation in the number of women in the
post-menopausal stage, who suffer from the weakening bones. The total number of
women attaining menopause is estimated to cross 1 bn. by 2025, according to the
International Menopause Society the number of menopausal women is higher in the
developing. Incidence rate of cancers like myeloma which cause loss of bone
density. Bisphosphonates are also used for therapy in the patients suffering
from breast cancer and prostate cancer. However bisphosphonate treatment has
some restraints, bisphosphonates cause some side-effects like upset stomach and
inflammation, erosion of esophagus and arterial fibrillation among some women.
This along with the presence of alternative therapies may hinder the growth of
the bisphosphonates market.

The
Global bisphosphonates
market is segmented on the basis of route of administration, therapeutic
areas and region

Segmentation
based on mode of delivery

·Oral

·Intravenous

Segmentation
based on therapeutic areas

·Cancer

·Myeloma

·Breast Cancer

·Prostate Cancer

·Others

·Degenerative bone diseases

·Osteoporosis

·Hypercalcemia

·Others

Segmentation
by Application

·Orthopedics

·Oncology

·Gynaecology

Segmentation
by Distribution Channel

·Hospitals

·Retail Pharmacies

·Online Pharmacies

With
the increasing geriatric population and bone related injuries the overall
market for bisphosphonates is increasing very rapidly. Moreover significant
increase in the healthcare spending will boost the bisphosphonates market
during the forecast period.

Geographically
the bisphosphonates market is segmented into five key regions: North America,
Latin America, Europe, Asia Pacific and MEA region.

North
America and Europe are currently leading in the bisphosphonates market due to
high per capita healthcare spending and high incidence of myeloma in this
regions. APAC is expected to show the highest growth rate in the bisphosphonate
market due to the high prevalence and incidence of osteoporosis cases and large
number of post-menopausal women. APAC region will show tremendous growth in the
bisphosphonates market during the forecast period followed by Latin America
mainly due to the increased healthcare spending by the governments for the
development of health of women. MEA will also follow up with Latin America
owing to the suitable demographics required for the growth of the
bisphosphonates market.

Some
major companies in the bisphosphonates market are Merck, Sanofi-Aventis, Roche,
Novartis, Proctor & Gamble and Pfizer

·Bisphosphonates Market Segments

·Bisphosphonates Market Dynamics

·Historical Actual Market Size, 2013 - 2015

·Bisphosphonates Treatment Market Size & Forecast 2016 to
2026

·Bisphosphonates Treatment Current Trends/Issues/Challenges

·Competition & Companies involved

·Bisphosphonates Market Drivers and Restraints

About
Us

Future
Market Insights (FMI) is a leading market intelligence and consulting firm. We
deliver syndicated research reports, custom research reports and consulting
services which are personalized in nature. FMI delivers a complete packaged
solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights and an aerial view of the
competitive framework and future market trends.